BACKGROUND This study aims to subdivide BI-RADS-MRI (Breast Imaging Reporting and Data System Magnetic Resonance Imaging) Category 4 lesions and to evaluate the role of Fischer's scoring system, apparent diffusion coefficient (ADC), and Fischer's + ADC in differential diagnosis of breast lesions. MATERIAL AND METHODS This study retrospectively analyzed the data of 143 patients (150 breast lesions), who were diagnosed by biopsy, and received dynamic contrast enhancement and diffusion-weighted imaging. The diagnostic efficacies of ADC, Fischer's scoring system, and the Fischer's + ADC were analyzed by the receiver operating characteristics curve. The area under the curve (AUC) was calculated. Fischer's scoring system and the Fischer's + ADC were used to subdivide BI-RADS Category 4 breast lesions. RESULTS ADC value was negatively correlated with the tumor grade. The AUC of Fischer's + ADC (0.949) was significantly higher than that of ADC (0.855) and Fischer's (0.912) (P=0.0008 and 0.001, respectively). Scored by Fischer's scoring system, Category 4 and 5 indicated a likely malignant threshold with sensitivity and specificity of 98.70% and 65.75%, respectively. Scored by the Fischer's + ADC method, Category 4B and 4C indicated a likely malignant threshold with sensitivity of 97.40% and specificity of 82.19%. Kappa values were 0.63 (ADC), 0.65 (Fischer's), and 0.80 (Fischer's + ADC), respectively. The positive predictive value of BI-RADS 4A, 4B, and 4C were 7.69%, 52.38% and 89.29%, respectively. CONCLUSIONS Fischer's scoring system combined with ADC could reasonably subdivide Category 4 breast lesions with high specificity and sensitivity.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5914275PMC
http://dx.doi.org/10.12659/msm.907000DOI Listing

Publication Analysis

Top Keywords

fischer's adc
24
fischer's scoring
20
scoring system
20
breast lesions
16
fischer's
13
adc
12
apparent diffusion
8
diffusion coefficient
8
breast imaging
8
imaging reporting
8

Similar Publications

Population pharmacokinetics of TLD-1, a novel liposomal doxorubicin, in a phase I trial.

Cancer Chemother Pharmacol

September 2024

Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universitaet Berlin, Kelchstr. 31, 12169, Berlin, Germany.

Article Synopsis
  • TLD-1 is a new formulation of pegylated liposomal doxorubicin designed to improve the balance between its effectiveness and side effects in treating cancer.
  • The study analyzed how TLD-1 behaves in the body (pharmacokinetics) using data from a clinical trial with 30 patients, looking specifically at drug concentrations and how they change over time.
  • Results showed TLD-1 has a longer half-life than existing treatments, suggesting it could be a strong candidate for future studies to better understand its effects on efficacy and toxicity in patients.
View Article and Find Full Text PDF

Background: The objective was to analyse if magnetic resonance imaging (MRI) can act as a non-radiation exposure surrogate for (18)F-Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in children with histologically confirmed Hodgkin lymphoma (HL) before treatment. This was done by analysing a potential correlation between apparent diffusion coefficient (ADC) in MRI and the maximum standardized uptake value (SUVmax) in FDG-PET/CT.

Patients And Methods: Seventeen patients (six female, eleven male, median age: 16 years, range: 12-20 years) with histologically confirmed HL were retrospectively analysed.

View Article and Find Full Text PDF

Our aim is to determine the diagnostic performance and utility of Diffusion Weighted MR Imaging (DWI) against the routine Magnetic Resonance Imaging (MRI) for the evaluation of patients with tendon injuries of the ankle and foot. After institutional review board approval and informed consent taken from all the patients, ankle and foot MR imaging and DWI-Apparent Diffusion Coefficient (ADC) mapping were performed on the 81 injured tendons of 50 patients. All tendon injuries were named as Rupture (R), Partial tear (PT), and Tenosynovitis (T).

View Article and Find Full Text PDF

BACKGROUND This study aims to subdivide BI-RADS-MRI (Breast Imaging Reporting and Data System Magnetic Resonance Imaging) Category 4 lesions and to evaluate the role of Fischer's scoring system, apparent diffusion coefficient (ADC), and Fischer's + ADC in differential diagnosis of breast lesions. MATERIAL AND METHODS This study retrospectively analyzed the data of 143 patients (150 breast lesions), who were diagnosed by biopsy, and received dynamic contrast enhancement and diffusion-weighted imaging. The diagnostic efficacies of ADC, Fischer's scoring system, and the Fischer's + ADC were analyzed by the receiver operating characteristics curve.

View Article and Find Full Text PDF

Analysis of the proliferative activity in lung adenocarcinomas with specific driver mutations.

Pathol Res Pract

March 2018

Institute of Pathology, University Heidelberg, Heidelberg, Germany; Translational Lung Research Centre Heidelberg, Member of the German Centre for Lung Research, Germany. Electronic address:

In the last decade it became evident that many lung adenocarcinomas (ADC) harbor key genetic alterations such as KRAS, EGFR or BRAF mutations as well as rearrangements of ROS1 or ALK that drive these tumors. In the present study we investigated whether different driver mutations of ADC result in different proliferation rates, which might have clinical impact, including resistance to therapy, recurrence and prognosis. We analyzed the proliferation index (PI) on full slides of surgically resected ADC (n = 230) with known genetic aberrations by means of immunohistochemistry and subsequent digital image analysis and correlated the results with clinicopathological variables including overall (OS) and disease free survival (DFS).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!